depemokimab-ulaa

depemokimab-ulaa (EXDENSUR) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.

EXDENSUR is a marketed brand name for depemokimab-ulaa. Check FDA Drugs@FDA for the current US label holder and prescribing information.

depemokimab-ulaa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.